Abercrombie george b - direct investment history in Biocryst pharmaceuticals inc

Filed on 2015-05-22 by Abercrombie George B SEC CIK 1485939 Form 4

Accession 0001127602-15-018268.txt Sec File: edgar/data/1485939/0001127602-15-018268-index.htm

2015-05-20 Abercrombie George B (CIK 1485939) through Direct

Invested in Biocryst Pharmaceuticals Inc bought 15000 shares at $0 remaining shares owned 15000

Automatic Stock Option Grant Biocryst Pharmaceuticals Inc Bcrx exercise date 2015-06-20 exercise price 11.39 has valueitem expiration due date 2025-05-20 underlying security shares 15000 underlying security title Common Stock

f1 automatic non-employee director grant pursuant to the biocryst pharmaceuticals, inc. stock incentive plan.
f2 vests 1/12th per month over twelve months beginning june 20, 2015.


Filed on 2014-05-06 by Abercrombie George B SEC CIK 1485939 Form 4

Accession 0001127602-14-016559.txt Sec File: edgar/data/1485939/0001127602-14-016559-index.htm

2014-05-02 Abercrombie George B (CIK 1485939) through Direct

Invested in Biocryst Pharmaceuticals Inc bought 15000 shares at $0 remaining shares owned 15000

Automatic Stock Option Grant Biocryst Pharmaceuticals Inc Bcrx exercise date 2014-06-02 exercise price 8.47 has valueitem expiration due date 2024-05-02 underlying security shares 15000 underlying security title Common Stock

f1 automatic non-employee director grant pursuant to the biocryst pharmaceuticals, inc. stock incentive plan.
f2 vests 1/12 per month over twelve months beginning june 2, 2014.


Filed on 2014-04-01 by Abercrombie George B SEC CIK 1485939 Form 4

Accession 0001127602-14-013014.txt Sec File: edgar/data/1485939/0001127602-14-013014-index.htm

2014-03-31 Abercrombie George B (CIK 1485939) through Direct

Invested in Biocryst Pharmaceuticals Inc sold 4000 shares at $0 remaining shares owned 11000

Automatic Stock Option Grant Biocryst Pharmaceuticals Inc Bcrx exercise date 2013-06-30 exercise price 1.71 has valueitem expiration due date 2023-05-31 underlying security shares 4000 underlying security title Common Stock


Filed on 2014-04-01 by Abercrombie George B SEC CIK 1485939 Form 4

Accession 0001127602-14-013014.txt Sec File: edgar/data/1485939/0001127602-14-013014-index.htm

2014-03-31 Abercrombie George B (CIK 1485939) through Direct

Invested in Biocryst Pharmaceuticals Inc bought 4000 shares at $1.71 remaining shares owned 10000

Common Stock Biocryst Pharmaceuticals Inc Bcrx Transaction code: M Exercise or conversion of derivative security


Filed on 2013-11-13 by Abercrombie George B SEC CIK 1485939 Form 4

Accession 0001127602-13-031483.txt Sec File: edgar/data/1485939/0001127602-13-031483-index.htm

2013-11-12 Abercrombie George B (CIK 1485939) through Direct

Invested in Biocryst Pharmaceuticals Inc bought 3000 shares at $6.19 remaining shares owned 6000

Common Stock Biocryst Pharmaceuticals Inc Bcrx Transaction code: P Open market or private purchase of securities

f1 the price reported in column 4 is a weighted average price. these shares were purchased in multiple transactions at prices ranging from $6.18 to $6.19, inclusive. the reporting person undertakes to provide to biocryst pharmaceuticals, inc., any security holder of biocryst pharmaceuticals, inc., or the staff of the securities and exchange commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.


Filed on 2013-06-03 by Abercrombie George B SEC CIK 1485939 Form 4

Accession 0001127602-13-019037.txt Sec File: edgar/data/1485939/0001127602-13-019037-index.htm

2013-05-31 Abercrombie George B (CIK 1485939) through Direct

Invested in Biocryst Pharmaceuticals Inc bought 15000 shares at $0 remaining shares owned 15000

Automatic Stock Option Grant Biocryst Pharmaceuticals Inc Bcrx exercise date 2013-06-30 exercise price 1.71 has valueitem expiration due date 2023-05-31 underlying security shares 15000 underlying security title Common Stock

f1 automatic non-employee director grant pursuant to the biocryst pharmaceuticals, inc. stock incentive plan.
f2 vests 1/12 per month over 12 months beginning june 30, 2013.


Filed on 2013-03-06 by Abercrombie George B SEC CIK 1485939 Form 4

Accession 0001127602-13-009645.txt Sec File: edgar/data/1485939/0001127602-13-009645-index.htm

2013-03-05 Abercrombie George B (CIK 1485939) through Direct

Invested in Biocryst Pharmaceuticals Inc bought 3000 shares at $1.23 remaining shares owned 3000

Common Stock Biocryst Pharmaceuticals Inc Bcrx Transaction code: P Open market or private purchase of securities


Filed on 2012-05-25 by Abercrombie George B SEC CIK 1485939 Form 4

Accession 0001127602-12-018160.txt Sec File: edgar/data/1485939/0001127602-12-018160-index.htm

2012-05-23 Abercrombie George B (CIK 1485939) through Direct

Invested in Biocryst Pharmaceuticals Inc bought 15000 shares at $0 remaining shares owned 15000

Automatic Stock Option Grant Biocryst Pharmaceuticals Inc Bcrx exercise date 2012-06-23 exercise price 3.32 has valueitem expiration due date 2022-05-23 underlying security shares 15000 underlying security title Common Stock

f1 automatic non-employee director grant pursuant to the biocryst pharmaceuticals, inc. stock incentive plan (the "plan").
f2 vest 1/12 per month over 12 months beginning june 23, 2012


Filed on 2011-10-11 by Abercrombie George B SEC CIK 1485939 Form 4

Accession 0001127602-11-027215.txt Sec File: edgar/data/1485939/0001127602-11-027215-index.htm

2011-10-10 Abercrombie George B (CIK 1485939) through Direct

Invested in Biocryst Pharmaceuticals Inc bought 16667 shares at $0 remaining shares owned 16667

Non-Qualified Stock Option Biocryst Pharmaceuticals Inc Bcrx exercise price 2.63 has valueitem expiration due date 2021-10-10 underlying security shares 16667 underlying security title Common Stock

f1 automatic non-employee director grant pursuant to the biocryst pharmaceuticals, inc. stock incentive plan (the "plan").
f2 the option vests 1/8 per month for a period of 8 months, beginning on october 10, 2011.